Cargando…
Linaclotide activates guanylate cyclase‐C/cGMP/protein kinase‐II‐dependent trafficking of CFTR in the intestine
The transmembrane receptor guanylyl cyclase‐C (GC‐C), expressed on enterocytes along the intestine, is the molecular target of the GC‐C agonist peptide linaclotide, an FDA‐approved drug for treatment of adult patients with Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipatio...
Autores principales: | Ahsan, Md. Kaimul, Tchernychev, Boris, Kessler, Marco M., Solinga, Robert M., Arthur, David, Linde, Cristina I., Silos‐Santiago, Inmaculada, Hannig, Gerhard, Ameen, Nadia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471438/ https://www.ncbi.nlm.nih.gov/pubmed/28592587 http://dx.doi.org/10.14814/phy2.13299 |
Ejemplares similares
-
Guanylate cyclase-C/cGMP: an emerging pathway in the regulation of visceral pain
por: Hannig, Gerhard, et al.
Publicado: (2014) -
Linaclotide induces secretion of cGMP from mouse colonic epithelium
por: Tchernychev, Boris, et al.
Publicado: (2013) -
Determination of cGMP levels in rodent tissues following oral dosing of a soluble guanylate cyclase stimulator
por: Perez, Nisha, et al.
Publicado: (2013) -
Metabolic fate of orally administered cGMP in rats
por: Liong, Elaine, et al.
Publicado: (2013) -
Linaclotide-induced electrolyte secretion in human and rat colon: Ussing chamber studies
por: Tchernychev, Boris, et al.
Publicado: (2015)